phosphotyrosine has been researched along with 2-phosphoglycerate in 1 studies
*2-phosphoglycerate: RN given refers to cpd without isomeric designation [MeSH]
*2-phosphoglycerate: RN given refers to cpd without isomeric designation [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alečković, M; Arellano, ML; Boggon, TJ; Chen, GZ; Chen, J; Elf, S; Fan, J; Gong, W; Gu, TL; He, C; Hitosugi, T; Jin, P; Kang, HB; Kang, S; Kang, Y; Khoury, HJ; Khuri, FR; LeRoy, G; Lonial, S; Seo, JH; Shan, C; Shin, DM; Wang, Y; Xie, J; Zhang, L; Zhou, L | 1 |
1 other study(ies) available for phosphotyrosine and 2-phosphoglycerate
| Article | Year |
|---|---|
Tyr26 phosphorylation of PGAM1 provides a metabolic advantage to tumours by stabilizing the active conformation.
Topics: 2,3-Diphosphoglycerate; Amino Acid Sequence; Animals; Cell Line, Tumor; Cell Proliferation; Enzyme Stability; Glyceric Acids; Glycolysis; Histidine; Humans; Mice; Models, Molecular; Molecular Sequence Data; Neoplasms; Phosphoglycerate Mutase; Phosphorylation; Phosphotyrosine | 2013 |